首页 > 市场调查报告书 > 食物/饮料

食品添加剂机能性食品

市场调查报告书

商品编码

1441281

人乳寡糖(HMO) 全球市场规模、份额、成长分析（按类型、按应用） - 产业预测，2023-2030 年

Global Human Milk Oligosaccharides (HMO) Market Size, Share, Growth Analysis, By Type(2'-FL & 3-FL, Sialyllactose), By Application(Segmented as, Infant Formula) - Industry Forecast 2023-2030

出版日期: 2024年02月17日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球人乳寡糖（HMO）市场规模为1.7791亿美元，从2023年的1.9517亿美元成长到2031年，预测期间（2024-2031年）复合年增长率为9.7%，预计将成长到2020 年将达4.0932 亿美元。

人乳寡糖（HMO）市场已被视为婴儿健康和营养的关键组成部分。 HMO 属于复杂碳水化合物，天然存在于母乳中，具有多种健康益处。这些生物活性化合物支持婴儿免疫系统、胃肠道健康和认知发展。随着对 HMO 认识的不断深入，其潜在应用范围已从婴儿营养扩展到医疗、机能性食品和益生元补充品等领域。提高大众对 HMO 健康益处的认识以及使婴儿配方奶粉更接近母乳的目标是市场成长的关键驱动力。 HMO 增强免疫和肠道健康的能力与自然和整体治疗方法的成长趋势不谋而合。研究和开发还包括识别和开发针对特定健康益处的独特 HMO 组合物。然而，HMO 生产的复杂性和成本带来了挑战，特别是在复製母乳中存在的各种 HMO 方面。监管考虑和潜在的智慧财产权障碍也会影响市场动态。随着 HMO 研究的进展，市场不仅在婴儿营养方面显示出前景，而且在满足不同生命阶段的各种健康需求方面也显示出前景。重新定义营养和健康概念的潜力凸显了 HMO 市场在塑造医药和机能性食品未来的重要性。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

DuPont Nutrition & Biosciences
Nestle SA
Glycosyn LLC
Jennewein Biotechnologie GmbH
Elicityl
Inbiose
ZuChem Inc.
Glycom A/S
TMO Renewables Ltd.
Abbott Laboratories
Evolve Biosystems
Quantum Biotechnologies Inc.
Novalac
ZuChem Inc.
Clasado Biosciences
Metabiotics Corporation
Medolac Laboratories
HMO Research GmbH
Jennewein Biotechnologie
Holton BioSystems

简介目录

Product Code: SQMIG30I2309

Global Human Milk Oligosaccharides (HMO) Market size was valued at USD 177.91 Million in 2022 and is poised to grow from USD 195.17 Million in 2023 to USD 409.32 Million by 2031, at a CAGR of 9.7% during the forecast period (2024-2031).

The market for human milk oligosaccharides (HMOs) is gaining prominence as a crucial component in infant wellness and nutrition. HMOs, categorized as complex carbohydrates, naturally occur in human breast milk and offer various health benefits. These bioactive compounds support the development of the infant's immune system, gastrointestinal health, and cognitive functions. As our understanding of HMOs expands, their potential applications extend beyond infant nutrition to fields like medicine, functional foods, and prebiotic supplements. Increasing public awareness of the health benefits of HMOs and the aim to make infant formula more akin to breast milk are key drivers of market growth. The ability of HMOs to enhance immunological and gut health aligns with the rising trend of seeking natural and holistic remedies. Research focus also includes identifying and developing unique HMO compositions to target specific health benefits. However, challenges in HMO production complexity and cost arise, particularly in replicating the diverse range of HMOs present in breast milk. Regulatory considerations and potential intellectual property obstacles also influence market dynamics. As research on HMOs advances, the market shows promise not just in infant nutrition but also in addressing various health needs across different stages of life. The potential to redefine the concept of nutrition and well-being underscores the significance of the HMO market in shaping the future of healthcare and functional foods.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Milk Oligosaccharides (HMO) and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Human Milk Oligosaccharides (HMO) Market Segmental Analysis

The Human Milk Oligosaccharides (HMO) Market is segmented on the basis of Type, Application, and Region. Based on Type, the market is segmented as, 2'-FL & 3-FL, Sialyllactose, LNT & LNnT. Based on Application the market is segmented as, Infant Formula, Functional Food & Beverages, Food/Medical Supplements, Others. Regional the market is segmented as, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA)

Drivers of the Global Human Milk Oligosaccharides (HMO) Market

The increasing recognition of the health benefits of human milk oligosaccharides (HMOs) is a significant driver for market growth. There is a rising demand for HMO-fortified products due to the role HMOs play in enhancing the immune system, cognitive development, and gut health in infants, as well as potential benefits for adults.

The incorporation of HMOs in formula products reflects consumers' desire for infant formulas that closely mimic the health advantages of breast milk. HMOs have become a vital component of infant nutrition as parents seek to provide their babies with optimal nourishment.

Restraints in the Global Human Milk Oligosaccharides (HMO) Market

The synthesis of HMOs is a challenging and intricate process. The scalability and cost-efficiency of manufacturing HMOs are hindered by the intricate and expensive methods required to replicate the diverse array of HMO structures found in breast milk.

It is essential to educate consumers about the benefits and importance of HMOs, especially in non-infant applications. While challenging, increasing awareness and understanding of the potential uses of HMOs is crucial for market growth.

Market Trends of the Global Human Milk Oligosaccharides (HMO) Market

Exploring Diverse Applications Beyond Infant Nutrition: While HMOs have traditionally been associated with infant feeding and are naturally present in breast milk, there is a growing trend to explore their potential in various other contexts. Researchers are investigating the use of HMOs in functional foods, dietary supplements, and pharmaceuticals to address a range of health conditions across different age groups.

Customization and HMO Profiling: As scientific understanding of HMOs advances, an increasing number of HMO profiles are being developed to closely mimic the composition of HMOs found in the breast milk of specific mothers. This customization offers the potential to provide new-borns with personalized nutrition tailored to their individual needs, as each mother's milk has a unique HMO composition.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Human Milk Oligosaccharides (HMO) Market by Type

Market Overview
2'-FL & 3-FL
Sialyllactose
LNT & LNnT

Global Human Milk Oligosaccharides (HMO) Market by Application

Market Overview
Segmented as
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
and Others

Global Human Milk Oligosaccharides (HMO) Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

DuPont Nutrition & Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nestle S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glycosyn LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jennewein Biotechnologie GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elicityl
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inbiose
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZuChem Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glycom A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TMO Renewables Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evolve Biosystems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quantum Biotechnologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novalac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZuChem Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clasado Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metabiotics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medolac Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HMO Research GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jennewein Biotechnologie
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Holton BioSystems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments